American Portfolios Advisors Harvard Bioscience Inc Transaction History

American Portfolios Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Mar 20, 2023	BUY	$3.28 - $6.42 $656 - $1,284	200 New	200 $720,000
Q1 2022 Mar 21, 2023	BUY	$5.16 - $7.14 $1,032 - $1,428	200 New	200 $1.24 Million
Q4 2021 Mar 21, 2023	BUY	$6.37 - $8.18 $1,274 - $1,636	200 New	200 $1.41 Million
Q3 2021 Mar 22, 2023	BUY	$6.98 - $8.47 $1,396 - $1,694	200 New	200 $1.4 Million

30.6M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

Stay updated on American Portfolios Advisors with notifications on news.